This paper describes work to improve the targeting of drug delivery for such infections by modifying intranasal spray usage protocols. Computational fluid dynamic studies and experimental validation work show that with an improved protocol, involving more shallowed (almost horizontal) angling of the intranasal spray, drug delivery to the nasopharyngeal viral infection ‘hot spot’ can be doubled. The optimal droplet size for drug delivery for such applications is discussed, and the robustness of the developed protocol is highlighted, with respect to the consistency of drug delivery.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Why Pharma should care about circular packaging – Futurity leading the way
Publications, Pharmaceutical, Sustainability, Device Innovations, Brand Differentiation, Product Solutions
Navigating the Development for Orally Inhaled and Nasal Drug Products
Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions
Using Intranasal Delivery for Drug Repositioning: A Compelling Proposition for Lifecy...
Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation
The Potential and Challenge of Nasal Vaccination
Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions
